Broadfin Capital, LLC - AMAG PHARMACEUTICALS INC ownership

AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 176 filers reported holding AMAG PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 1.59 and the average weighting 0.1%.

Quarter-by-quarter ownership
Broadfin Capital, LLC ownership history of AMAG PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2019$1,155,000
-90.4%
100,000
-83.3%
0.21%
-88.6%
Q1 2018$12,066,000
+33.2%
598,800
+99.6%
1.88%
+237.5%
Q4 2015$9,057,000
-81.5%
300,000
-73.8%
0.56%
-73.8%
Q4 2014$48,888,000
+1.4%
1,147,060
-24.1%
2.12%
-58.0%
Q3 2014$48,209,000
-40.7%
1,510,775
-61.5%
5.05%
+26.4%
Q2 2014$81,254,000
+384.3%
3,921,550
+352.3%
4.00%
+146.0%
Q1 2014$16,779,000867,1171.62%
Other shareholders
AMAG PHARMACEUTICALS INC shareholders Q2 2018
NameSharesValueWeighting ↓
Broadfin Capital, LLC 3,921,550$81,254,0004.00%
Palo Alto Investors LP 1,614,536$33,453,0002.49%
Ghost Tree Capital, LLC 100,000$2,072,0001.46%
March Altus Capital Management LP 146,418$3,034,0001.11%
IRONWOOD INVESTMENT MANAGEMENT LLC 296,458$6,143,0000.98%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 999,339$20,706,0000.83%
Visium Asset Management, LP 2,070,870$42,908,0000.67%
AlphaOne Investment Services, LLC 97,448$2,019,0000.54%
CONTINENTAL ADVISORS LLC 57,438$1,190,0000.28%
Tamarack Capital Management, LLC 64,080$1,222,0000.25%
View complete list of AMAG PHARMACEUTICALS INC shareholders